Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Surgery Partners (SGRY) Accumulated Depreciation & Amortization (2016 - 2025)

Surgery Partners' Accumulated Depreciation & Amortization history spans 12 years, with the latest figure at $176.0 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 15.33% year-over-year to $176.0 million; the TTM value through Dec 2025 reached $176.0 million, up 15.33%, while the annual FY2025 figure was $176.0 million, 15.33% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $176.0 million at Surgery Partners, up from $39.5 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $272.3 million in Q4 2021 and bottomed at $25.7 million in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $50.2 million (2024), against an average of $88.1 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 117.52% in 2021 before it tumbled 57.84% in 2022.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $272.3 million in 2021, then crashed by 57.84% to $114.8 million in 2022, then grew by 2.87% to $118.1 million in 2023, then increased by 29.21% to $152.6 million in 2024, then increased by 15.33% to $176.0 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Accumulated Depreciation & Amortization are $176.0 million (Q4 2025), $39.5 million (Q3 2025), and $40.3 million (Q2 2025).